About this course
In patients with atrial fibrillation (AF), stroke prevention remains as one of the cornerstones of management. This is accomplished using either vitamin K antagonists or non-vitamin K antagonist oral anticoagulants (NOACs). The use of NOACs has led to improved clinical outcomes in AF patients in terms of stroke prevention. This e-learning module summarizes important information health care practitioners can use and advise their patients about NOACs, including data on their efficacy and safety, their guidelines-based indications, and reversal agents available in case of NOAC-induced bleeding.
Upon completion of the educational activity, health care providers should be able to:
- Understand the importance of stroke prevention in patients with AF
- Learn the difference between Vitamin K antagonists and NOACS
- Identify the 4 approved NOACs and their uses based on clinical guidelines
- Learn about reversal agents available in case of NOAC-induced bleeding
- Introduction (stroke prevention in AF, stroke risk stratification, Vitamin K antagonists versus NOACs)
- Studies and trials on the 4 approved NOACs
- NOACs in the guidelines
- Different types of reversal agents
- Patient specific indications for using each NOAC
- Acceptability, accessibility, and affordability of NOACs
1 CME Point Available
- This module is accredited for 1 CME Point for medical practitioners enrolled in The Medical Council of Hong Kong’s Continuing Medical Education Programme for Practising Doctors who are not taking CME for Specialists.
- This module is accredited for both Hong Kong Doctors Union (HKDU) members and non-members.
- A certificate can be downloaded upon successful completion of the quiz. Please use the information on the certificate to claim your CME points.